Refine
Has Fulltext
- yes (13)
Is part of the Bibliography
- yes (13)
Document Type
- Journal article (13)
Language
- English (13)
Keywords
- measles virus (5)
- T cells (3)
- sphingomyelinase (3)
- T cell receptor (2)
- T cell receptors (2)
- ceramide (2)
- dendritic cell (2)
- neutral sphingomyelinase-2 (2)
- plasma membrane (2)
- sphingosine-1-phosphate (2)
- 3D tissue model (1)
- ATP-adenosine triphosphate (1)
- Biologie (1)
- Dendritische Zelle (1)
- LFA-1 (1)
- Mitochondria (1)
- PKCζ, (1)
- Seahorse XF (1)
- T cell (1)
- T cell migration (1)
- T cell silencing (1)
- TCR signaling cascade (1)
- Virologie (1)
- actins (1)
- activation (1)
- adhesion (1)
- alternative splicing (1)
- cell cycle and cell division (1)
- cell membrane (1)
- cell migration (1)
- ceramides (1)
- cholesteryl ester (1)
- cytoskeleton (1)
- diacylglycerol (1)
- enzymes (1)
- flow cytometry (1)
- gene regulation (1)
- genetic interference (1)
- immunosuppression (1)
- lyso-phospholipids (1)
- motility (1)
- neutral sphingomyelinase (1)
- neutral sphingomyelinase 2 (1)
- oxidative phosphorylation (1)
- polarization (1)
- reverse transcriptase-polymerase chain reaction (1)
- sphingolipid (1)
- the microtubule-organizing center (1)
- tyrosine (1)
- virus budding (1)
- virus entry (1)
- virus replication (1)
Neutral sphingomyelinase-2 (NSM2) is a member of a superfamily of enzymes responsible for conversion of sphingomyelin into phosphocholine and ceramide at the cytosolic leaflet of the plasma membrane. Upon specific ablation of NSM2, T cells proved to be hyper-responsive to CD3/CD28 co-stimulation, indicating that the enzyme acts to dampen early overshooting activation of these cells. It remained unclear whether hyper-reactivity of NSM2-deficient T cells is supported by a deregulated metabolic activity in these cells. Here, we demonstrate that ablation of NSM2 activity affects metabolism of the quiescent CD4\(^+\) T cells which accumulate ATP in mitochondria and increase basal glycolytic activity. This supports enhanced production of total ATP and metabolic switch early after TCR/CD28 stimulation. Most interestingly, increased metabolic activity in resting NSM2-deficient T cells does not support sustained response upon stimulation. While elevated under steady-state conditions in NSM2-deficient CD4\(^+\) T cells, the mTORC1 pathway regulating mitochondria size, oxidative phosphorylation, and ATP production is impaired after 24 h of stimulation. Taken together, the absence of NSM2 promotes a hyperactive metabolic state in unstimulated CD4\(^+\) T cells yet fails to support sustained T cell responses upon antigenic stimulation.
Sphingolipids are essential components of eukaryotic cells. In this review, we want to exemplarily illustrate what is known about the interactions of sphingolipids with various viruses at different steps of their replication cycles. This includes structural interactions during entry at the plasma membrane or endosomal membranes, early interactions leading to sphingolipid-mediated signal transduction, interactions with internal membranes and lipids during replication, and interactions during virus assembly and budding. Targeted interventions in sphingolipid metabolism – as far as they can be tolerated by cells and organisms – may open novel possibilities to support antiviral therapies. Human immunodeficiency virus type 1 (HIV-1) infections have intensively been studied, but for other viral infections, such as influenza A virus (IAV), measles virus (MV), hepatitis C virus (HCV), dengue virus, Ebola virus, and severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), investigations are still in their beginnings. As many inhibitors of sphingolipid metabolism are already in clinical use against other diseases, repurposing studies for applications in some viral infections appear to be a promising approach.